Prior studies on maternal mortality largely focused on deaths in the conventional time frame of 42 days after a live-birth delivery, often excluding women with a stillbirth.
1
Others relied on a pregnancy checkbox on the death certificate and then submitted to a central repository 2 or did not evaluate injury, 3 which has emerged as an important cause of late maternal death 43e365 days postpartum. 4 Herein we included stillbirths and provided more discrete time intervals to evaluate injury-specific causes of maternal mortality.
STUDY DESIGN:
We studied live births and stillbirths from 20 weeks' gestation onward, from 1990 through 2015, in Ontario, Canada, where health care is universally available. Provincial databases of all hospital deliveries and Vital Statistics, including mandatory completed death certificates, 5 were linked using unique encoded identifiers at the Institute for Clinical Evaluative Sciences. The Research Ethics Board of the Sunnybrook Health Sciences Centre granted ethics approval. Incidence rates (IRs) were separately calculated for injury and noninjury maternal deaths. IRs were shown across 11 time intervals within the 365 days after birth: biweekly from 0 to 42 days (when deaths are most common) and every 6 weeks thereafter. To account for the changing number of women at risk in each interval and the time at risk therein, IRs were presented per 1 million person-weeks, with 95% confidence intervals (CIs). The proportion of deaths caused by injury in each interval was also calculated and the corresponding trend tested by a 2-sided Cochrane-Armitage test. Maternal deaths caused by injury at 0e42 and 43e365 days were presented by injury subtype: transport accident (International Classification of Diseases, ninth edition [ICD-9] E800eE849); accidental poisoning/overdose (ICD-9 E850eE854); intentional selfharm (ICD-9 E950eE959); assault/homicide (ICD-9 E960eE969); or other (ICD-9 E855eE949 and E970eE999).
RESULTS:
Of 3,179,157 births, there were 760 maternal deaths within 365 days of delivery (23.9 per 100,000, 95% CI, 22.2e25.6), including 720 deaths among 3,159,762 livebirths (22.8 per 100,000, 95% CI, 21.1e24.5), and 40 deaths among 19,395 stillbirths (206.2 per 100,000, 95% CI, 142.4e270.1). There were 235 maternal deaths within 42 days of birth (IR, 12.3 per 1 million person-weeks, 95% CI, 10.7e14.0) and 525 deaths from 43 to 365 days (IR, 3.6 per 1 million personweeks, 95% CI, 3.3e3.9) (Figure 1, bars) . In the first 14 days after birth, injuries caused 4.1% of maternal deaths; by 28 days, they accounted for 35e48% of all deaths (P < .001) (Figure 1, top red) . Greater than 60% of injuryrelated deaths were from self-harm, poisoning/overdose, and homicide ( Figure 1, bottom circles) .
CONCLUSION:
Greater than 95% of maternal deaths before 14 days postpartum were due to noninjury causes, as described Maternal mortality incidence rates for injury and noninjury deaths Maternal mortality incidence rates for injury (orange bars) and noninjury (blue bars) deaths occurring at various intervals from birth to 42 days (early deaths) and from 43 to 365 days (late deaths). Incidence rates and 95% confidence intervals (CI) are presented per 1 million person-weeks by women at risk in the denominators. The proportion of deaths caused by injury are shown in each time interval and tested by the CochraneArmitage test for trend (top red). Injury-related deaths are further broken down by subtype at 0e42 and 43e365 days (lower circles). 1e3 Thereafter, injury-related deaths rose significantly, with more than one third of injuries being intentional, a similar proportion to that in a study of 129 maternal deaths in Australia. 4 This study did not capture out-of-hospital births, which are less than 1% of births in Ontario, or maternal deaths occurring antepartum. Although direct and indirect causes of death were not differentiated herein, the striking difference in maternal mortality rates following a stillbirth vs a livebirth deserves further study. Future studies should further classify maternal deaths by injury subtypes, including overdoses, and additionally evaluate antepartum deaths.
Human term amniotic fluid: a novel source of stem cells for regenerative medicine
OBJECTIVE:
Our objective was to characterize term amniotic fluid stem cells and compare them with previously described mid-trimester amniotic fluid stem cells. Stem cells are undifferentiated cells with the ability to self-replicate without differentiation. Mid-trimester amniotic fluid stem cells have been well-characterized as multipotent, but scant data exist for term amniotic fluid.
1 With the advent of noninvasive prenatal diagnosis, mid-trimester amniotic fluid will become less available from normal patients. In contrast, term amniotic fluid is available in large quantities from normal pregnancies and might be a resource for clinical transplantation.
STUDY DESIGN:
Institutional Review Board approval and informed consent were obtained before research began. Amniotic fluid was collected from uncomplicated, scheduled term cesarean deliveries with a small uterine incision and a soft catheter to collect fluid before the attempt to deliver the baby. Immediately after collection, cell viability from each fresh sample was assayed before culture with the use of Trypan Blue staining; cells were counted via hemocytometer. Cells were then cultured for expansion; aliquots were taken and frozen from each subsequent passage. Cells were seeded on gridded culture dishes and counted daily for 4 days to assess proliferation. Flow cytometry for surface markers
